These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 31298938)

  • 21. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
    Kiri VA; Fabbri LM; Davis KJ; Soriano JB
    Respir Med; 2009 Jan; 103(1):85-90. PubMed ID: 18793832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the risk of hospitalizations due to chronicobstructive pulmonary disease in medicaid patients with various medication regimens, including ipratropium, inhaled corticosteroids, salmeterol, or their combination.
    Rascati KL; Stanford RH; Borker R
    Clin Ther; 2005 Mar; 27(3):346-54. PubMed ID: 15878389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled Corticosteroids Particle Size and Risk of Hospitalization Due to Exacerbations and All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease. A Nationwide Cohort Study.
    Heerfordt CK; Rønn C; Eklöf J; Sivapalan P; Harboe ZB; Hyldgaard C; Fløe A; Mathioudakis AG; Lassen MCH; Biering-Sørensen T; Jensen JS
    Int J Chron Obstruct Pulmon Dis; 2024; 19():2169-2179. PubMed ID: 39364225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hospitalization for chronic obstructive pulmonary disease and pneumonia: association with the dose of inhaled corticosteroids. A nation-wide cohort study of 52 100 outpatients.
    Rønn C; Sivapalan P; Eklöf J; Kamstrup P; Biering-Sørensen T; Bonnesen B; Harboe ZB; Browatzki A; Kjærgaard JL; Meyer CN; Jensen TT; Johansson SL; Bendstrup E; Ulrik CS; Stæhr Jensen JU
    Clin Microbiol Infect; 2023 Apr; 29(4):523-529. PubMed ID: 36503112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD).
    Chalmers JD; Poole C; Webster S; Tebboth A; Dickinson S; Gayle A
    Respir Res; 2018 Apr; 19(1):63. PubMed ID: 29642882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk for pneumonia requiring hospitalization or emergency room visit according to delivery device for inhaled corticosteroid/long-acting beta-agonist in patients with chronic airway diseases as real-world evidence.
    Park JH; Kim Y; Choi S; Jang EJ; Kim J; Lee CH; Yim JJ; Yoon HI; Kim DK
    Sci Rep; 2019 Aug; 9(1):12004. PubMed ID: 31427602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of Opioid-related Adverse Pulmonary Events among Older Adults with Chronic Obstructive Pulmonary Disease.
    Vozoris NT; Pequeno P; Li P; Austin PC; O'Donnell DE; Gershon AS
    Ann Am Thorac Soc; 2020 Aug; 17(8):965-973. PubMed ID: 32396385
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhaled corticosteroids and the risk of lung cancer in COPD: a population-based cohort study.
    Raymakers AJN; Sadatsafavi M; Sin DD; FitzGerald JM; Marra CA; Lynd LD
    Eur Respir J; 2019 Jun; 53(6):. PubMed ID: 30956205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial.
    Tashkin DP; Miravitlles M; Celli BR; Metzdorf N; Mueller A; Halpin DMG; Anzueto A
    Respir Res; 2018 Oct; 19(1):196. PubMed ID: 30290801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled corticosteroids can reduce osteoporosis in female patients with COPD.
    Liu SF; Kuo HC; Liu GH; Ho SC; Chang HC; Huang HT; Chen YM; Huang KT; Chen KY; Fang WF; Lin MC
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1607-14. PubMed ID: 27478374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled Corticosteroids Increase the Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study.
    Lee MC; Lee CH; Chien SC; Chang JH; She HL; Wang JY; Yu MC
    Medicine (Baltimore); 2015 Oct; 94(42):e1723. PubMed ID: 26496284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
    Gillissen A; Haidl P; Khlhäufl M; Kroegel K; Voshaar T; Gessner C
    Dtsch Arztebl Int; 2016 May; 113(18):311-6. PubMed ID: 27215595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study.
    Magnussen H; Lucas S; Lapperre T; Quint JK; Dandurand RJ; Roche N; Papi A; Price D; Miravitlles M;
    Respir Res; 2021 Jan; 22(1):25. PubMed ID: 33478491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials.
    Yang M; Du Y; Chen H; Jiang D; Xu Z
    Int Immunopharmacol; 2019 Dec; 77():105950. PubMed ID: 31629940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased Pneumonia Risk Associated with Concomitant Use of Inhaled Corticosteroids and Benzodiazepines: A Pharmacovigilance Analysis.
    Ma J; Liu Y; Sun Y; Guo C; Yang G
    Lung; 2024 Oct; 202(5):673-681. PubMed ID: 39191908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain).
    Román-Rodríguez M; van Boven JF; Vargas F; Contreras CC; Lamelas G; Gestoso S; Góngora M; Corredor M; Esteva M
    Eur J Gen Pract; 2016 Dec; 22(4):232-239. PubMed ID: 27597172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study.
    Morjaria JB; Rigby A; Morice AH
    Lung; 2017 Jun; 195(3):281-288. PubMed ID: 28255905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection, and Pneumonia Risk in Chronic Obstructive Pulmonary Disease. A Network Analysis.
    Martinez-Garcia MA; Faner R; Oscullo G; de la Rosa D; Soler-Cataluña JJ; Ballester M; Agusti A
    Am J Respir Crit Care Med; 2020 May; 201(9):1078-1085. PubMed ID: 31922913
    [No Abstract]   [Full Text] [Related]  

  • 39. Prehospital use of inhaled corticosteroids and point prevalence of pneumonia at the time of hospital admission: secondary analysis of a multicenter cohort study.
    Festic E; Bansal V; Gajic O; Lee AS;
    Mayo Clin Proc; 2014 Feb; 89(2):154-62. PubMed ID: 24485129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of Pneumonia Associated with Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease: A Korean Population-Based Study.
    Lee JH; Park YH; Kang DR; Lee SJ; Lee MK; Kim SH; Yong SJ; Lee WY
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3397-3406. PubMed ID: 33402820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.